Literature DB >> 6693424

Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor.

K P Fairbanks, L D Witte, D S Goodman.   

Abstract

Relationships between mevalonate and DNA synthesis were explored in quiescent human fibroblasts stimulated with human platelet-derived growth factor (PDGF). Studies of others have indicated that mevalonate, or a product of mevalonate other than cholesterol, is essential for DNA replication. The present studies were designed to determine whether there was a critical time in the cell cycle when mevalonate was necessary for later DNA synthesis to occur. Compactin and mevinolin, inhibitors of hydroxymethylglutaryl CoA reductase, were employed to block both the synthesis of mevalonate and of DNA. Compactin inhibited the sharp peak of DNA synthesis which occurs in cells 24 h after PDGF addition in a concentration-dependent manner. This suppression of DNA synthesis was not prevented by low density lipoprotein but was fully reversed by mevalonate. Compactin inhibited DNA synthesis when the inhibitor was present during the time interval 10-20 h after PDGF addition. Its presence only in the interval before 10 h or after 20 h had no effect. Conversely, mevalonate could fully overcome the compactin block in DNA synthesis when present during the period of from 10-20 h after PDGF addition. Mevalonate present only before 10 h or after 20 h had no effect. When mevalonate was added to mevinolin-blocked cells for the interval 10-15 h after PDGF, the mevinolin block of DNA synthesis was 68% overcome; in contrast, only 20% of the reversal of the mevinolin block was seen when mevalonate was added from 15-20 h. Addition of mevalonate for only the 2-h interval of from 10-12 h after PDGF overcame the mevinolin block of DNA synthesis (assayed at 24 h) by 50%. The results show that there is a critical time period, several h before S phase, when PDGF-stimulated cells require mevalonate in order for DNA synthesis to proceed at 24 h. This critical period comprised the interval of approximately 10-20 h after PDGF addition and especially the early part of this interval.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693424

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  In vitro and in vivo antiproliferative effects of simvastatin, an HMG-CoA reductase inhibitor, on human glioma cells.

Authors:  T Kikuchi; Y Nagata; T Abe
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

2.  Mevalonate is essential for growth of porcine and human vascular smooth muscle cells in vitro.

Authors:  G Rogler; K J Lackner; G Schmitz
Journal:  Basic Res Cardiol       Date:  1995 Nov-Dec       Impact factor: 17.165

3.  Role of cholesterol in the development and progression of breast cancer.

Authors:  Gemma Llaverias; Christiane Danilo; Isabelle Mercier; Kristin Daumer; Franco Capozza; Terence M Williams; Federica Sotgia; Michael P Lisanti; Philippe G Frank
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Defective macromolecule biosynthesis and cell-cycle progression in a mammalian cell starved for mevalonate.

Authors:  M Sinensky; J Logel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cells.

Authors:  R Asslan; A Pradines; G Favre; F Le Gaillard
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

6.  Cholesterol and prostaglandin synthesis by cultured human skin fibroblasts in the Alagille syndrome involving paucity of interlobular bile ducts.

Authors:  J Dupont; J Raulin; M Gautier; D Lapous; C Loriette; S Kuan; J Stewart; B Krumhardt
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

7.  Activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase does not respond to ubiquinone uptake in cultured cells.

Authors:  W A Maltese; J R Aprille; R A Green
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

8.  The effect of mevalonic acid deprivation on enzymes of DNA replication in cells emerging from quiescence.

Authors:  J R Silber; H Galick; J M Wu; M D Siperstein
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

9.  Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Authors:  P H Berry; J S MacDonald; A W Alberts; S Molon-Noblot; J S Chen; C Y Lo; M D Greenspan; H Allen; G Durand-Cavagna; R Jensen
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

10.  Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Authors:  W A Maltese; R Defendini; R A Green; K M Sheridan; D K Donley
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.